Dr. Harald Hasselmann
Harald Hasselmann, born in Hamburg, has gained extensive experience at various international pharmaceutical companies. He was head of controlling for Europe at Bayer Pharma, managing director at Schering’s Hungarian subsidiary and director of the Berlin-based biotech company metaGen. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, controlling and implementing restructuring measures. With effect from October 1, 2015, Hasselmann became Managing Director for Sales and Finances. In June 2016, he was elected in the Board of Directors.
After completing his studies of electrical engineering he started his career in production and material management. Before joining the Eckert & Ziegler Group he worked as a production manager with MKS AsteX GmbH, a manufacturer of systems for the semiconductor industry. He gained extensive experiences in lean manufacturing and various quality management methods. In 2008, he joined the Eckert & Ziegler Group, initially as Production Manager and later as Manager of Operation and Member of the General Management within the Radiopharma Segment. With effect from January 1, 2017, Warmuth became a Member of the Management Committee and will be responsible for Development, Quality and Production.